Machine Learning in the ICU: Predicting Mortality in Bloodstream Infections (ICU:Intensive Care Unit)
ICU
1 other identifier
observational
197
1 country
1
Brief Summary
Using our own patient data, our study aimed to predict mortality that can develop in Carbapenem-resistant Gram-negative bacilli bloodstream infections with a machine learning-based model. In the intensive care unit, patients with bloodstream infections, both with and without mortality, will be examined retrospectively in two subgroups for comparison.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
December 12, 2023
CompletedStudy Start
First participant enrolled
April 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2025
CompletedMarch 11, 2026
March 1, 2026
1.2 years
December 4, 2023
March 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk of Mortality
The sensitivity and specificity will be defined with AUC-ROC curve (Area Under the Receiver Operating Characteristic curve) using machine learning algorithm
3 months
Study Arms (2)
Deceased Patients
Carbapenem-resistant Gram-negative bacilli Blood Stream Infection With mortality
Surviving Patients
Carbapenem-resistant Gram-negative bacilli Blood Stream Infection Without mortality
Interventions
Using deep learning we try to develop an algorithm and anticipate mortality
Eligibility Criteria
All patients who were monitored in our tertiary intensive care unit for six years retrospectively and developed bloodstream infections with Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa have been included in the study with their personal data anonymized
You may qualify if:
- In our study, patients who were monitored in our hospital's tertiary Intensive Care Unit between June 2017 and June 2023 and developed bloodstream infections with Carbapenem-resistant Enterobacteriaceae, Carbapenem-resistant Acinetobacter baumannii and Carbapenem-resistant Pseudomonas aeruginosa will be retrospectively included.
You may not qualify if:
- Patients under the age of 18 and those with infections other than bloodstream infections will not be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kocaeli University
Kocaeli, Turkey (Türkiye)
Related Publications (1)
Guler O, Alparslan V, Inner B, Balci S, Duzgun A, Baykara N, Kus A. Machine Learning in the ICU: Predicting Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli Bloodstream Infections. J Intensive Care Med. 2026 Mar 16:8850666261423499. doi: 10.1177/08850666261423499. Online ahead of print.
PMID: 41837809DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
özlem güler
Kocaeli University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Phd Medical Doctor
Study Record Dates
First Submitted
December 4, 2023
First Posted
December 12, 2023
Study Start
April 12, 2024
Primary Completion
June 28, 2025
Study Completion
June 28, 2025
Last Updated
March 11, 2026
Record last verified: 2026-03